SVStock Value LensFree historical stock research100% free

Loading stock chart…

FREE HISTORICAL COMPANY DATA

Pfizer (PFE) financial history

NYSE · USD · Health Care · CIK 0000078003

Pharmaceuticals · Company classification source

Annual coverage
2007-12-31–2025-12-31 (19 periods)
Latest fiscal period
2025-12-31
Prices through
2026-05-08 · historical, not live
Available metrics
Basic EPS, Diluted EPS, FCF/share, Dividends/share

Financial snapshot built 2026-08-27. Current membership snapshot: 2026-10-08. Prices and available dividend yields use Stooq adjusted-close approximations.

Pfizer diluted EPS history

19 stored annual diluted-EPS observations cover fiscal periods ending 2007-12-31–2025-12-31. The latest stored diluted EPS is 1.36 USD for the period ending 2025-12-31. View filing (2026-02-26)

Read the complete annual table or select Diluted EPS in the chart above. Learn to compare price with earnings.

Pfizer free cash flow per share history

19 stored annual FCF/share observations cover fiscal periods ending 2007-12-31–2025-12-31. The latest stored free cash flow per share is 1.59 USD for the period ending 2025-12-31. Operating cash flow (2026-02-26) · Capex (2026-02-26)

FCF/share is derived from operating cash flow minus capital expenditure, divided by matching annual diluted weighted-average shares. Select FCF / share in the chart above to explore it. Compare EPS and FCF per share.

Charts and CSV/PNG exports are free, without signup. Download and read the chart CSV. The export follows the selected chart window and metric; the annual table below retains the full stored history.

Tables and factual summaries are generated automatically from the stored snapshot. Maintained by Cheng. Sources & limitations.

PFE annual financial history

All stored annual observations, independent of the chart window. Per-share amounts in USD. Unavailable values are not zero.

Dividend yields marked Approx. use Stooq adjusted closes. See the calculation and limitations.

Annual EPS, cash flow, dividends, and fiscal-year dividend yield for Pfizer
Fiscal year / endBasic EPSDiluted EPSFCF / shareDividends / shareFiscal-year dividend yieldFiling sources
2025
2025-12-31
1.371.361.591.726.86% Approx.Basic EPS (2026-02-26)
Diluted EPS (2026-02-26)
Operating cash flow (2026-02-26) · Capex (2026-02-26)
Dividend (2026-02-26)
2024
2024-12-31
1.421.411.731.696.35% Approx.Basic EPS (2026-02-26)
Diluted EPS (2026-02-26)
Operating cash flow (2026-02-26) · Capex (2026-02-26)
Dividend (2026-02-26)
2023
2023-12-31
0.380.370.841.655.73% Approx.Basic EPS (2026-02-26)
Diluted EPS (2026-02-26)
Operating cash flow (2026-02-26) · Capex (2026-02-26)
Dividend (2026-02-26)
2022
2022-12-31
5.595.474.541.613.14% Approx.Basic EPS (2025-02-27)
Diluted EPS (2025-02-27)
Operating cash flow (2025-02-27) · Capex (2025-02-27)
Dividend (2025-02-27)
2021
2021-12-31
3.923.855.231.572.75% Approx.Basic EPS (2024-02-22)
Diluted EPS (2024-02-22)
Operating cash flow (2024-02-22) · Capex (2024-02-22)
Dividend (2024-02-22)
2020
2020-12-31
1.651.632.161.534.46% Approx.Basic EPS (2023-02-23)
Diluted EPS (2023-02-23)
Operating cash flow (2023-02-23) · Capex (2023-02-23)
Dividend (2023-02-23)
2019
2019-12-31
2.882.821.861.464.15% Approx.Basic EPS (2022-02-24)
Diluted EPS (2022-02-24)
Operating cash flow (2022-02-24) · Capex (2022-02-24)
Dividend (2022-02-24)
2018
2018-12-31
1.901.872.321.383.72% Approx.Basic EPS (2021-02-25)
Diluted EPS (2021-02-25)
Operating cash flow (2021-02-25) · Capex (2021-02-25)
Dividend (2021-02-25)
2017
2017-12-31
3.573.522.451.304.31% Approx.Basic EPS (2020-02-27)
Diluted EPS (2020-02-27)
Operating cash flow (2020-02-27) · Capex (2020-02-27)
Dividend (2020-02-27)
2016
2016-12-31
1.181.172.331.224.68% Approx.Basic EPS (2019-02-28)
Diluted EPS (2019-02-28)
Operating cash flow (2019-02-28) · Capex (2019-02-28)
Dividend (2019-02-28)
2015
2015-12-31
1.131.112.121.124.49% Approx.Basic EPS (2018-02-22)
Diluted EPS (2018-02-22)
Operating cash flow (2018-02-22) · Capex (2018-02-22)
Dividend (2018-02-22)
2014
2014-12-31
1.441.422.471.044.39% Approx.Basic EPS (2017-02-23)
Diluted EPS (2017-02-23)
Operating cash flow (2017-02-23) · Capex (2017-02-23)
Dividend (2017-02-23)
2013
2013-12-31
3.233.192.390.964.34% Approx.Basic EPS (2016-02-29)
Diluted EPS (2016-02-29)
Operating cash flow (2016-02-29) · Capex (2016-02-29)
Dividend (2016-02-29)
2012
2012-12-31
1.961.942.050.885.06% Approx.Basic EPS (2015-02-27)
Diluted EPS (2015-02-27)
Operating cash flow (2015-02-27) · Capex (2015-02-27)
Dividend (2015-02-27)
2011
2011-12-31
1.281.272.360.805.50% Approx.Basic EPS (2014-02-28)
Diluted EPS (2014-02-28)
Operating cash flow (2014-02-28) · Capex (2014-02-28)
Dividend (2014-02-28)
2010
2010-12-31
1.031.021.230.726.30% Approx.Basic EPS (2013-02-28)
Diluted EPS (2013-02-28)
Operating cash flow (2013-02-28) · Capex (2013-02-28)
Dividend (2013-02-28)
2009
2009-12-31
1.231.232.18UnavailableUnavailableBasic EPS (2012-02-28)
Diluted EPS (2012-02-28)
Operating cash flow (2012-02-28) · Capex (2012-02-28)
2008
2008-12-31
1.201.202.45UnavailableUnavailableBasic EPS (2011-02-28)
Diluted EPS (2011-02-28)
Operating cash flow (2011-02-28) · Capex (2011-02-28)
2007
2007-12-31
1.181.171.65UnavailableUnavailableBasic EPS (2010-02-26)
Diluted EPS (2010-02-26)
Operating cash flow (2010-02-26) · Capex (2010-02-26)

Pfizer (PFE) P/E ratio history

The interactive P/E chart contains all 1305 stored weekly price points (2001-05-11–2026-05-08); 958 have an eligible basic or diluted ratio. Annual EPS is carried forward from its fiscal end. Use the P/E range bar or the valuation range bar to change both chart windows.

Fiscal-year-end snapshots

19 eligible fiscal-year-end observations span 2007-12-31–2025-12-31. Latest eligible diluted P/E: 18.45×; basic P/E: 18.31×, for fiscal end 2025-12-31, using the close on 2025-12-26.

Annual P/E = eligible fiscal-year-end close ÷ reported annual EPS. Adjusted-close ratios are approximate. This is retrospective annual P/E, not TTM or forward P/E. Missing or non-positive EPS and missing eligible prices produce unavailable ratios.

Explore the P/E chart and optional reference lines · How P/E history is calculated.

Complete annual P/E history (19 fiscal periods)
Full stored fiscal-year-end P/E history, independent of the selected chart window. Ratios in ×; prices in USD.
Fiscal endPrice dateClosePrice basisBasic P/EDiluted P/EEPS filings
2025-12-312025-12-2625.09Adjusted close · Approx.18.3118.45Basic EPS (2026-02-26) Diluted EPS (2026-02-26)
2024-12-312024-12-2726.62Adjusted close · Approx.18.7518.88Basic EPS (2026-02-26) Diluted EPS (2026-02-26)
2023-12-312023-12-2928.79Adjusted close · Approx.75.7677.81Basic EPS (2026-02-26) Diluted EPS (2026-02-26)
2022-12-312022-12-3051.24Adjusted close · Approx.9.179.37Basic EPS (2025-02-27) Diluted EPS (2025-02-27)
2021-12-312021-12-3157.19Adjusted close · Approx.14.5914.86Basic EPS (2024-02-22) Diluted EPS (2024-02-22)
2020-12-312020-12-3134.31Adjusted close · Approx.20.7921.05Basic EPS (2023-02-23) Diluted EPS (2023-02-23)
2019-12-312019-12-2735.21Adjusted close · Approx.12.2312.49Basic EPS (2022-02-24) Diluted EPS (2022-02-24)
2018-12-312018-12-2837.09Adjusted close · Approx.19.5219.84Basic EPS (2021-02-25) Diluted EPS (2021-02-25)
2017-12-312017-12-2930.19Adjusted close · Approx.8.468.58Basic EPS (2020-02-27) Diluted EPS (2020-02-27)
2016-12-312016-12-3026.05Adjusted close · Approx.22.0822.27Basic EPS (2019-02-28) Diluted EPS (2019-02-28)
2015-12-312015-12-3124.95Adjusted close · Approx.22.0822.48Basic EPS (2018-02-22) Diluted EPS (2018-02-22)
2014-12-312014-12-2623.67Adjusted close · Approx.16.4416.67Basic EPS (2017-02-23) Diluted EPS (2017-02-23)
2013-12-312013-12-2722.14Adjusted close · Approx.6.856.94Basic EPS (2016-02-29) Diluted EPS (2016-02-29)
2012-12-312012-12-2817.40Adjusted close · Approx.8.888.97Basic EPS (2015-02-27) Diluted EPS (2015-02-27)
2011-12-312011-12-3014.56Adjusted close · Approx.11.3711.46Basic EPS (2014-02-28) Diluted EPS (2014-02-28)
2010-12-312010-12-3111.42Adjusted close · Approx.11.0911.20Basic EPS (2013-02-28) Diluted EPS (2013-02-28)
2009-12-312009-12-3111.87Adjusted close · Approx.9.659.65Basic EPS (2012-02-28) Diluted EPS (2012-02-28)
2008-12-312008-12-2611.16Adjusted close · Approx.9.309.30Basic EPS (2011-02-28) Diluted EPS (2011-02-28)
2007-12-312007-12-2814.94Adjusted close · Approx.12.6612.77Basic EPS (2010-02-26) Diluted EPS (2010-02-26)

WHY USE STOCK VALUE LENS

Free historical stock charts, P/E history and financial data

Explore weekly P/E ratio history using annual EPS and compare earnings and cash flow per share with historical stock prices, with clear coverage and source links.

P/E ratio history using annual EPS
Free approximate P/E at every stored weekly price, using basic or diluted annual EPS carried forward from fiscal end. Includes a synchronized P/E range bar and optional 15× / 20× / 30× references. Missing and non-positive EPS leave gaps. Retrospective, not TTM or forward P/E.
Free, including exports
All current charts and CSV/PNG exports are free. No account or subscription required.
Long annual histories
PFE: 19 annual diluted EPS observations (2007-12-31–2025-12-31); 19 annual FCF/share observations (2007-12-31–2025-12-31). Coverage varies by metric; histories may have gaps.
Historical weekly prices
PFE: weekly price observations from 2001-05-11 through 2026-05-08. Prices are historical, not live quotes.
Filing-linked financial data
EPS facts link to SEC filings. FCF/share is derived from reported cash-flow inputs and diluted shares. Historical prices come from Stooq.

Financial database built 2026-08-27. FCF/share is a derived measure; adjusted prices and associated dividend yields are labeled approximations. The formula line is a retrospective reference, not an intrinsic-value estimate. Verify sources, dates and limitations.

Browse the S&P 500 company directory or search 6,551 US-listed securities. Metric coverage varies.